Newcastle biotechnology company ImmVirX Pty Limited has treated the first cancer patient in the clinical trial of its bio-selected oncolytic virus, IVX037.
The Newcastle Jets 2010/11 season was the Jets’ sixth season since the inception of the A-League. It proved to be a tumultuous period in the club’s history. On 15 October 2010, new ownership group under mining magnate Nathan Tinkler, showed its commitment to the Hunter with a new club strip, emblazoned with the HMRI logo.
Early Career Researcher of the Year 2022, Associate Professor Michelle Kennedy from the Equity in Health and Wellbeing Research Program, is driving a fresh new way of conducting community-based research – and the results are closing the gap.
In a world first, Newcastle researchers have discovered the mechanisms acute myeloid leukaemia (AML) cells use to produce ‘free radicals’ – the byproduct of a cell process that aggressively fuels the growth of cancer cells and limits the effectiveness of current treatments.
In 1998, HMRI took the first step on a journey that would lead us to become one of the world’s premier medical research organisations. Fast forward 25 years and HMRI’s Director, Professor Frances Kay-Lambkin has lit the birthday candles on a year-long celebration. Speaking at the official launch this week, Frances is excited for what is ahead.